{"id":"W2094875652","doi":"10.1160/th13-07-0543","title":"Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome","year":2014,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Takeda Pharmaceuticals North America","keywords":"Medicine; TIMI; Placebo; Acute coronary syndrome; Myocardial infarction; Incidence (geometry); Clinical endpoint; Internal medicine; Thrombolysis; Gastroenterology; Dose; Adverse effect; Surgery; Anesthesia; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001909462,0.0001746261,0.0006264244,0.0001762571,0.00007613574,0.00002137994,0.00006351791,0.00006335326,0.00009410243],"category_scores_gemma":[0.00003244869,0.0001473219,0.00009453371,0.0002212098,0.00003156073,0.0002499599,0.00007800089,0.0000754653,0.000005157369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003155171,"about_ca_system_score_gemma":0.00001232981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001265609,"about_ca_topic_score_gemma":0.00003591275,"domain_scores_codex":[0.9987203,0.00008984804,0.0004043614,0.0002746063,0.0003175288,0.0001933516],"domain_scores_gemma":[0.9994367,0.00004688201,0.0001153829,0.0002493221,0.00004033473,0.000111344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002695697,0.0007406982,0.9745027,0.00003071525,0.0002930422,0.000008681003,0.001111491,0.000001222523,0.0002413904,0.00002344831,0.00007527458,0.02270177],"study_design_scores_gemma":[0.01773629,0.005312011,0.9751309,0.00004892602,0.0004238488,8.766546e-7,0.0006439859,0.00008040748,0.0002122176,0.0000186872,0.0002381458,0.0001537088],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987055,0.00001861365,0.0000132308,0.000157441,0.0001843882,0.0007726368,0.00001898182,0.00003563315,0.00009354354],"genre_scores_gemma":[0.999489,0.00002219002,0.0002117596,0.00009389009,0.00003983337,0.000003275842,0.00006669591,0.00002225228,0.00005108827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02254806,"threshold_uncertainty_score":0.6007614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1054999647114413,"score_gpt":0.3864084300958795,"score_spread":0.2809084653844382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}